rituximab
English
Alternative forms
- IDEC-C2B8
Etymology
From [Term?] + -tu- (“tumor”) + -ximab (“chimeric monoclonal antibody”).
Pronunciation
- (General American) IPA(key): /ɹɪˈtʌk.sɪˌmæb/
Noun
rituximab (usually uncountable, plural rituximabs)
- (pharmacology) A chimeric monoclonal antibody (trademark Rituxan) administered by intravenous injection especially to treat non-Hodgkin lymphoma and chronic lymphocytic leukemia by binding to the protein CD20 found on the surface of B cells and causing their lysis.
References
- “rituximab”, in Merriam-Webster Online Dictionary, Springfield, Mass.: Merriam-Webster, 1996–present.
Spanish
Pronunciation
- IPA(key): /rituɡsiˈmab/ [ri.t̪uɣ̞.siˈmaβ̞]
- Rhymes: -ab
- Syllabification: ri‧tu‧xi‧mab
Noun
rituximab f (plural rituximabs)